Marshall Wace’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Buy |
+143,312
| New | +$1.28M | ﹤0.01% | 1641 |
|
|
2024
Q4 | – | Sell |
-33,257
| Closed | -$253K | – | 2390 |
|
|
2024
Q3 | $253K | Buy |
+33,257
| New | +$253K | ﹤0.01% | 2049 |
|
|
2023
Q4 | – | Sell |
-134,362
| Closed | -$951K | – | 1849 |
|
|
2023
Q3 | $951K | Buy |
+134,362
| New | +$951K | ﹤0.01% | 1280 |
|
|
2023
Q2 | – | Sell |
-126,699
| Closed | -$1.06M | – | 2021 |
|
|
2023
Q1 | $1.06M | Buy |
+126,699
| New | +$1.06M | ﹤0.01% | 1397 |
|
|
2022
Q3 | – | Sell |
-35,574
| Closed | -$376K | – | 2569 |
|
|
2022
Q2 | $376K | Sell |
35,574
-1,050,272
| -97% | -$11.1M | ﹤0.01% | 2255 |
|
|
2022
Q1 | $17.7M | Buy |
+1,085,846
| New | +$17.7M | 0.03% | 508 |
|
|
2021
Q2 | – | Sell |
-182,905
| Closed | -$1.86M | – | 2113 |
|
|
2021
Q1 | $1.86M | Buy |
+182,905
| New | +$1.86M | 0.01% | 1173 |
|
|
2020
Q3 | – | Sell |
-50,277
| Closed | -$239K | – | 1536 |
|
|
2020
Q2 | $239K | Sell |
50,277
-21,383
| -30% | -$102K | ﹤0.01% | 1344 |
|
|
2020
Q1 | $143K | Buy |
+71,660
| New | +$143K | ﹤0.01% | 1243 |
|
|
2014
Q3 | – | Sell |
-218,413
| Closed | -$2.79M | – | 879 |
|
|
2014
Q2 | $2.79M | Buy |
+218,413
| New | +$2.79M | 0.04% | 344 |
|